SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-19-026756
Filing Date
2019-05-16
Accepted
2019-05-16 10:33:41
Documents
4
Period of Report
2019-06-18
Effectiveness Date
2019-05-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A tv521748_def14a.htm DEF 14A 477850
2 GRAPHIC tv521748_img1.jpg GRAPHIC 80500
3 GRAPHIC tv521748_proxy1.jpg GRAPHIC 327823
4 GRAPHIC tv521748_proxy2.jpg GRAPHIC 385108
  Complete submission text file 0001144204-19-026756.txt   1572259
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32295 | Film No.: 19830845
SIC: 2836 Biological Products, (No Diagnostic Substances)